CytoSorbents Corporation
(NASDAQ : CTSO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading CTSO News...
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.11%89.190.6%$430.57m
ABTAbbott Laboratories
-0.39%49.080.8%$380.47m
ISRGIntuitive Surgical, Inc.
-0.55%948.947.5%$324.23m
ALGNAlign Technology, Inc.
2.55%153.506.2%$292.66m
BDXBecton, Dickinson and Company
0.05%195.161.3%$285.09m
BCRC. R. Bard, Inc.
0.09%316.251.6%$252.30m
TMOThermo Fisher Scientific Inc.
-0.62%174.381.0%$212.41m
BAXBaxter International Inc.
1.14%61.371.7%$206.18m
BSXBoston Scientific Corporation
0.86%28.101.1%$187.50m
SYKStryker Corporation
-0.06%141.131.3%$167.20m
EWEdwards Lifesciences Corporation
1.36%120.141.2%$134.41m
ZBHZimmer Biomet Holdings, Inc.
-0.22%129.101.7%$133.11m
HOLXHologic, Inc.
-0.77%46.131.6%$119.46m
IDXXIDEXX Laboratories, Inc.
0.50%167.353.6%$117.39m
COOCooper Companies, Inc.
0.46%246.192.2%$116.40m

Company Profile

CytoSorbents Corp. is a critical care immunotherapy company, which engages in blood purification to control deadly inflammation in critically-ill and cardiac surgery patients. Its products include cytosorb, contrastsorb, vetresq, hemodefend, and drugsorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.,06J02W-E